Back to results

TerminatedPhase 2

Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer

NCT01069796

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre Paul Papin

Angers, France

+16 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2010-04
Enrollment: 64 participants
Sponsor: ARCAGY/ GINECO GROUP
Purpose: treatment

Locations (17)

Centre Paul PapinAngers, France
Clinique TivoliBordeaux, France
Centre Hospitalier William MoreyChalon-sur-Saône, France
Centre Hospitalier IntercommunalFréjus, France
Clinique des 4 PavillonsLormont, France
Hôpital Privé ClairvalMarseille, France
Centre Azuréen de CancérologieMougins, France
Centre Alexis VautrinNancy, France
Centre Antoine LacassagneNice, France
Centre Hospitalier RégionalOrléans, France
Institut Jean GodinotReims, France
Hôpitaux Drôme Nord - Site de Romans-sur-IsèreRomans-sur-Isère, France
Centre Henri BecquerelRouen, France
Clinique Armoricaine de RadiologieSaint-Brieuc, France
Clinique de l'UnionSt.-Jean, France
Centre Paul StraussStrasbourg, France
Centre Hospitalier Bretagne AtlantiqueVannes, France

Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer — TrialFind